PER 1.22% 8.1¢ percheron therapeutics limited

Combined Therapies for DMD, page-97

  1. 4,692 Posts.
    lightbulb Created with Sketch. 1089
    I doubt there is any Board that would agree to proceed to Phase2b based only on “interesting” scientific data.

    “Interesting” is not a scientific term used to qualify outcomes.

    ATL1102 halted disease progression....that is why they’re moving to Phase 2b.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
-0.001(1.22%)
Mkt cap ! $73.02M
Open High Low Value Volume
8.3¢ 8.5¢ 8.1¢ $11.95K 143.9K

Buyers (Bids)

No. Vol. Price($)
3 89519 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 262404 2
View Market Depth
Last trade - 15.58pm 11/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.